Skip to main content
. Author manuscript; available in PMC: 2024 Nov 15.
Published in final edited form as: Eur J Med Chem. 2023 Aug 28;260:115772. doi: 10.1016/j.ejmech.2023.115772

Figure 17.

Figure 17.

X-ray structures of Mpro in complex with representative peptidomimetic covalent inhibitors. (a, c, e) The active site of Mpro (shown as an electrostatic surface) in complex with (a) 11a (PDB: 6LZE), (c) 13b (PDB: 6Y2G) and (e) nirmatrelvir (PDB: 7RFW); (b, d, f) The Mpro-inhibitor interactions for (b) 11a, (d) 13b and (f) nirmatrelvir. Hydrogen bonds are shown as yellow dashed lines.